A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Bristol-Myers Squibb
AstraZeneca
Valent Technologies, LLC
ITM Solucin GmbH
BeiGene
Ipsen
Leaf Vertical Inc.
AbbVie
Merck Sharp & Dohme LLC